Apeloa Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Apeloa Pharmaceutical Co Ltd cash flow reinvestment rate. Apeloa Pharmaceutical Co Ltd (000739) has a Cash Flow Reinvestment Rate of 0.38x as of December 2025, reinvesting CN¥168.67 Million (capex CN¥166.73 Million plus investments CN¥1.94 Million) from operating cash flow of CN¥446.18 Million. Explore Apeloa Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Apeloa Pharmaceutical Co Ltd (1998–2025)
Cash flow reinvestment rate of Apeloa Pharmaceutical Co Ltd from 1998 to 2025. Historical reinvestment intensity for Apeloa Pharmaceutical Co Ltd across 26 annual periods. Explore reinvestment intensity of Apeloa Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Apeloa Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (1998–2025)
Apeloa Pharmaceutical Co Ltd cash flow reinvestment rate by year from 1998 to 2025. Year-by-year capital reinvestment analysis for Apeloa Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Apeloa Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.35x | CN¥435.36 Million | CN¥1.23 Billion | CN¥386.21 Million | ▼ -17.0% |
| 2024 | 0.43x | CN¥515.11 Million | CN¥1.21 Billion | CN¥460.75 Million | ▼ -66.4% |
| 2023 | 1.27x | CN¥1.31 Billion | CN¥1.03 Billion | CN¥630.47 Million | ▲ +226.5% |
| 2022 | 0.39x | CN¥514.89 Million | CN¥1.33 Billion | CN¥509.11 Million | ▼ -70.1% |
| 2021 | 1.30x | CN¥794.48 Million | CN¥611.75 Million | CN¥701.92 Million | ▲ +96.6% |
| 2020 | 0.66x | CN¥699.74 Million | CN¥1.06 Billion | CN¥317.12 Million | ▲ +130.1% |
| 2019 | 0.29x | CN¥390.45 Million | CN¥1.36 Billion | CN¥31.85 Million | ▲ +30.6% |
| 2018 | 0.22x | CN¥183.02 Million | CN¥832.69 Million | CN¥81.62 Million | ▼ -82.6% |
| 2017 | 1.26x | CN¥264.82 Million | CN¥209.80 Million | CN¥163.42 Million | ▼ -63.9% |
| 2016 | 3.50x | CN¥631.12 Million | CN¥180.42 Million | CN¥331.35 Million | ▲ +240.8% |
| 2015 | 1.03x | CN¥452.75 Million | CN¥441.16 Million | CN¥452.06 Million | ▲ +49.4% |
| 2014 | 0.69x | CN¥540.22 Million | CN¥786.64 Million | CN¥540.22 Million | ▼ -74.1% |
| 2013 | 2.65x | CN¥505.01 Million | CN¥190.45 Million | CN¥505.01 Million | ▲ +162.3% |
| 2012 | 1.01x | CN¥339.59 Million | CN¥335.90 Million | CN¥339.59 Million | ▲ +41.4% |
| 2011 | 0.71x | CN¥289.21 Million | CN¥404.62 Million | CN¥289.21 Million | ▼ -38.1% |
| 2010 | 1.15x | CN¥139.81 Million | CN¥121.05 Million | CN¥139.81 Million | ▲ +156.9% |
| 2009 | 0.45x | CN¥93.66 Million | CN¥208.30 Million | CN¥93.66 Million | ▼ -87.8% |
| 2008 | 3.69x | CN¥349.04 Million | CN¥94.57 Million | CN¥349.04 Million | ▲ +455.7% |
| 2007 | 0.66x | CN¥115.70 Million | CN¥174.20 Million | CN¥115.70 Million | ▲ +96.7% |
| 2006 | 0.34x | CN¥53.84 Million | CN¥159.43 Million | CN¥53.84 Million | ▼ -75.7% |
| 2005 | 1.39x | CN¥121.65 Million | CN¥87.40 Million | CN¥121.65 Million | ▼ -40.4% |
| 2004 | 2.34x | CN¥111.07 Million | CN¥47.54 Million | CN¥111.07 Million | ▲ +179.4% |
| 2003 | 0.84x | CN¥88.09 Million | CN¥105.36 Million | CN¥88.09 Million | ▼ -95.0% |
| 2002 | 16.78x | CN¥47.23 Million | CN¥2.81 Million | CN¥47.23 Million | ▲ +3595.5% |
| 2000 | 0.45x | CN¥3.22 Million | CN¥7.08 Million | CN¥3.22 Million | ▼ -16.8% |
| 1998 | 0.55x | CN¥16.43 Million | CN¥30.10 Million | CN¥16.43 Million | — |